Clinical trials recruiting for Lupus Nephritis (LN)
20
Recruiting trials
8
US states with sites
10
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 2 |
| Pennsylvania | 2 |
| District of Columbia | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Minnesota | 1 |
| Texas | 1 |
Top cities
Philadelphia, Pennsylvania 2Boston, Massachusetts 1Chicago, Illinois 1Hawthorne, New York 1Houston, Texas 1Lawrenceville, Georgia 1New Hyde Park, New York 1New York, New York 1Rochester, Minnesota 1Washington D.C., District of Columbia 1
Self-screener
Recruiting trials
- A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
- A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
- A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
- CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
- Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
- Dapagliflozin in Active Lupus Nephritis
- Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
- High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)
- Research Accelerated by You Lupus Registry
- Safety and Efficacy of ONT01 in Lupus
- Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
- The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
- The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population
Related conditions
Trials recruiting for Lupus Nephritis (LN) often also study these conditions. Each links to its own recruiting-trial list.
Lupus 332Systemic lupus erythematosus 119Inflammatory Myopathy 9Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 9Antiphospholipid Syndrome (APS) 3Systemic Sclerosis (SSc) 28Systemic Lupus Erthematosus (SLE) 8Sjogren's Syndrome 25Rheumatoid arthritis 314Membranous Nephropathy 3
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lupus Nephritis (LN) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.